NASDAQ · STOCK
Pfizer Inc.
$25.03
52W $23.11 – $28.75
56/100
$142.54B
19.1
0.31
Is PFE Bullish or Bearish?
Bullish.
Innellis AI committee rates Pfizer Inc. (PFE) Buy with a composite score of 56/100
, based on 6 analysts with 83% agreement.
Last updated July 31, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +18.57 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -1.43 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
Some positive signals exist — news sentiment is positive (+0.20 across 96 articles, 14d) — but they are not yet strong enough to justify a Buy. The committee is monitoring for confirmation.
Bull & Bear Case
Bull Case
- Dividend yield of 6.9% pays you to wait — Value
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- News sentiment is positive (+0.20 across 96 articles, 14d) — News
Bear Case
- EPS declining -5.3% YoY despite any revenue growth — Growth
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of July 31, 2026
Overall Committee Score
56/100
Agreement
83%
Analysts
6
Conviction
High
Sector Rank
Top 47%
of 93 Healthcare peers
Value Analyst
neutral
58
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ Dividend yield of 6.9% pays you to wait
Growth Analyst
neutral
56
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ 4 consecutive earnings beats -- consistent execution
− EPS declining -5.3% YoY despite any revenue growth
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Macro Analyst
neutral
58
/ 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
64
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 96 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Investment Thesis Evolution
Committee score moved marginally from 57.3 to 56.4.
- Conviction changed from moderate to high.
- Committee agreement increased notably from 67% to 83%.
- New bearish signals: 2 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 3 appeared.
- Bearish pressure eased: 2 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst.
Analyst-level changes:
- Macro Analyst: stance bullish->neutral; score 65->58 (-8); +1 bullish signal(s).
- News Analyst: +1 bullish signal(s).
- Portfolio Manager: +2 bearish signal(s).
- Value Analyst: +1 bullish signal(s).
Comparing 2026-07-30 to 2026-07-31 (1 day apart).
Technical Analysis
RSI (14)
55.5
Neutral
MACD Histogram
0.084
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Mixed
Support
$24.84
Resistance
$26.05
Bollinger %B
0.72
Inside Bands
Price vs Moving Averages
EMA 9
$24.92
Above
EMA 21
$24.83
Above
EMA 50
$25.11
Below
EMA 200
$25.67
Below
Fundamental Analysis
Valuation
94
Growth
94
Profitability
0
Financial Health
63
Cash Flow
37
Valuation
P/E Ratio
19.1×
P/B Ratio
1.58×
PEG Ratio
-3.32
Dividend Yield
0.07%
52W High
$28.75
52W Low
$23.11
Quality & Growth
ROE
9.0%
ROA
3.7%
Gross Margin
69.3%
Operating Margin
23.4%
Revenue Growth YoY
—
Debt / Equity
0.72
AI Fundamental Assessment
P/E ratio of 19.1 (inexpensive relative to a 15-40x range); Price-to-book of 1.6x; PEG ratio of -3.3 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.1%; Return on assets of 0.0%; Net margin of 0.1%; Gross margin of 0.7%; Current ratio of 1.25 (tight short-term liquidity); Debt-to-equity of 0.72; Free cash flow margin of 0.8% (thin cash generation); Free cash flow per share is positive (1.67); Most recent quarter beat estimates by 3.5%; 4 consecutive earnings beats; EPS growth accelerating (-24.1% -> +13.6% QoQ); Analyst estimates rising over recent quarters
Get the Full PFE Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →